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History of safe use
Digestibility
Toxicitya b s t r a c t
DroughtGard™maize was developed through constitutive expression of cold shock protein B (CSPB) from
Bacillus subtilis to improve performance of maize (Zea mays) under water-limited conditions. B. subtilis
commonly occurs in fermented foods and CSPB has a history of safe use. Safety studies were performed
to further evaluate safety of CSPB introduced into maize. CSPB was compared to proteins found in current
allergen and protein toxin databases and there are no sequence similarities between CSPB and known
allergens or toxins. In order to validate the use of Escherichia coli-derived CSPB in other safety studies,
physicochemical and functional characterization conﬁrmed that the CSPB produced by DroughtGard™
possesses comparable molecular weight, immunoreactivity, and functional activity to CSPB produced
from E. coli and that neither is glycosylated. CSPB was completely digested with sequential exposure
to pepsin and pancreatin for 2 min and 30 s, respectively, suggesting that CSPB will be degraded in the
mammalian digestive tract and would not be expected to be allergenic. Mice orally dosed with CSPB at
2160 mg/kg, followed by analysis of body weight gains, food consumption and clinical observations,
showed no discernible adverse effects. This comprehensive safety assessment indicated that the CSPB
protein from DroughtGard™ is safe for food and feed consumption.
 2015 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction CSPs, CSPB is composed of ﬁve antiparallel b-strands forming aWater availability is the most important factor limiting crop
productivity in dry and semi-dry land areas (Castiglioni et al.,
2008). It has been demonstrated that the expression of bacterial
cold shock proteins (CSPs) in plants can confer improved drought
stress adaptation in multiple plant species (Castiglioni et al.,
2008). To improve performance of maize (Zea mays) under
water-limited conditions, expression of the gene encoding cold
shock protein B (CSPB) has been used to develop a drought-toler-
ant maize, DroughtGard™ (Castiglioni et al., 2008; Harrigan
et al., 2009). CSPB, from the bacterial species Bacillus subtilis,
belongs to the family of single-stranded nucleic acid binding pro-
teins that contain a highly conserved cold shock domain (CSD)
(Zeeb and Balbach, 2003). Structurally similar to other bacterialﬁve-strand b-barrel, and possesses two conserved RNA binding
ribonucleoprotein motifs found in other RNA-binding proteins
(Bienert et al., 2004; Manival et al., 2001). Functionally, CSPs are
generally considered to help cell survival at low temperatures by
destabilizing RNA secondary structures (Graumann et al., 1997;
Max et al., 2006; Mussgnug et al., 2005; Phadtare and Inouye,
1999; Phadtare et al., 2002; Yamanaka et al., 1998). In bacteria,
some CSPs rapidly accumulate in response to temperature reduc-
tion, while others, including CSPB, are present not only in low tem-
perature conditions but also under optimal growth conditions and
after entry into the stationary phase (Graumann et al., 1997). Addi-
tionally, CSPs are involved in maintaining normal cellular functions
under nutrient limitation (Anderson et al., 2006).
CSD-containing proteins have also been identiﬁed in various
plant species including rice, wheat and barley (Chaikam and
Karlson, 2008; Karlson and Imai, 2003). B. subtilis, the source of
the cspb gene inserted into DroughtGard™maize through recombi-
nant DNAmethods, is a microorganism with a history of safe use in
fermented foods and probiotics (De Boer and Diderichsen, 1991;
Hosoi et al., 2003; Sanders et al., 2003). B. subtilis is used in produc-
tion of thua nao, popular in Asian food as a condiment for enhancing
ﬂavor in soups and curries, and natto, a commonly consumed food
in Japan for hundreds of years, made by fermenting cooked
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et al., 2006). In addition, B. subtilis is Generally Recognized As Safe
(GRAS) by the US Food and Drug Administration (U.S. FDA) for
use in themanufacturing of enzyme preparations to be used in food
(FDA, 1999; OECD, 2001). These common uses support the conclu-
sion that B. subtilis is safe for human consumption (Pedersen et al.,
2002; Sorokulova et al., 2008).
Due to the food uses of B. subtilis and other CSP-containing bac-
teria, as well as of plant proteins with CSDs, a history of safe expo-
sure for this protein is well established. Therefore, according to
Codex guidance and the tiered approach advocated by the Interna-
tional Life Sciences Institute, there is no safety concern for CSPB
consumption (Codex Alimentarius, 2009; Delaney et al., 2008a;
Hammond et al., 2013). However, to explicitly assess whether
the CSPB introduced into maize is safe for food and feed consump-
tion, safety assessments of this protein were performed prior to
commercialization of DroughtGard™. Here we describe processes
for evaluating the safety of CSPB, which was according to guidance
documents (Codex Alimentarius, 2009; Gao et al., 2004; Harrison
et al., 1996; Herouet et al., 2005; Raybould et al., 2013).2. Materials and methods
2.1. Puriﬁcation of CSPB from Escherichia coli
The deduced amino acid sequence of the cspb gene expressed in
DroughtGardTM is identical to that of the cspb gene from B. subtilis,
with the exception of a substitution that results in valine, rather
than leucine, at position 2 of the deduced sequence. The appropri-
ate cspb coding sequence was ligated into pET24b (Novagen, Mad-
ison, WI) and expressed in BL21 (DE3) E. coli (Invitrogen, Carlsbad,
CA). Fermentation was performed with 240 L of a medium contain-
ing Tryptone 10 g/L, Yeast extract 5 g/L, sodium chloride 5 g/L and
Kanamycin 50 mg/L. The CSPB protein expression was induced by
addition of isopropyl-1-thio-b-galactopyranoside to a ﬁnal concen-
tration of 0.5 mM at 37 C overnight. The E. coli cell paste was
resuspended in 50 mM Tris, pH 8.0, 10 mM KCl and 1 mM EDTA
extraction buffer at approximately a 1:5 sample weight to buffer
volume ratio. Cells were disrupted by a microﬂuidizer followed
by incubation with Benzonase at 20 units/ml. The cell lysate
was clariﬁed by centrifugation. Ammonium sulfate was slowly
added to the clariﬁed extract to a ﬁnal saturation of 40%. After cen-
trifugation, the supernatant was loaded onto a Phenyl Sepharose 6
Fast Flow column (All chromatography resins were from GE
Healthcare, Piscataway, NJ) and eluted with a linear salt gradient
that decreased from 1.7 to 0 M (NH4)2SO4 in the 50 mM phosphate
pH 7.0 buffer. After dialysis, the pooled CSPB containing fraction
was then loaded on a Q Sepharose Fast Flow column and eluted
with a linear salt gradient that increased from 0 M to 0.5 M NaCl
in a buffer of 20 mM Tris, pH 8.0 over 10-fold bed volumes. The
CSPB-containing fractions were pooled and concentrated using
dialysis tubing (Spectrum laboratories, Inc, Rancho Dominguez,
CA) [Molecular Weight Cut Off (MWCO): 3500] against Aquacide
I. This concentrated CSPB sample was further polished using a size
exclusion column (S100, Sephacryl, GE Healthcare, Piscataway, NJ)
equilibrated and eluted with a buffer of 20 mM Tris, pH 8.0. CSPB-
containing fractions were pooled as the ﬁnal fraction.2.2. Puriﬁcation of CSPB from grain of DroughtGard™ maize
CSPB protein was extracted from 10 kg of the grain powder of
DroughtGard™ with 100 L of Tris–Borate buffer (89 mM Tris–
Borate, 2 mM EDTA, pH 8.3) and incubated overnight at 4 C with
constant stirring. Diatomaceous earth (Advanced Minerals Corp,
Goleta, CA) was added to a ﬁnal concentration of 7.5% (w/v) andmixed for 3 h prior to ﬁltration. The ﬁnal slurry was ﬁltered using
an Ertel Alsop ﬁlter press (Kingston, NY) with Die 42 micro media
ﬁlter pads and a Cuno ﬁlter (Hagedorn & Gannon Co., Inc.). The ﬁl-
trate was then concentrated by diaﬁltration using a polysulfone
hollow ﬁber cartridge with a 3000 MWCO (GE Healthcare, Piscata-
way, NJ). Ammonium sulfate was slowly added to the concentrated
extract to a ﬁnal saturation of 40% and was allowed to dissolve
overnight at 4 C. After centrifugation, the pellet was discarded
and the supernatant collected and diaﬁltrated against buffer A
(20 mM Tris, pH 7.0),
The diaﬁltrated sample was separated by a Q Sepharose Fast
Flow column as described above. The CSPB-containing fractions
were pooled and concentrated using diaﬁltration as described
above. The concentrated sample containing CSPB was re-circulated
over an immunoafﬁnity column utilizing a mouse anti-CSPB mono-
clonal antibody (raised against the E. coli-expressed CSPB protein)
immobilized onto AminoLink resin (Pierce, Rockford, IL). Bound
CSPB was eluted using 100 mM triethylamine buffer, pH 11 and
neutralized with 1/20th volume of 1 M sodium phosphate, pH
6.8. The process was repeated multiple times until most of CSPB
present in the pool was captured. This immunoafﬁnity-enriched
CSPB fraction was further polished by size exclusion chromatogra-
phy as described above using buffer A. The CSPB containing frac-
tions were pooled and concentrated sequentially by diaﬁltration
with a mini cartridge (GE Healthcare, Piscataway, NJ) and by dial-
ysis (Slide-A-Lyzer dialysis cassette MWCO: 3500, size: 0.5–3 ml,
Pierce, Rockford, IL) against Aquacide I.
2.3. Protein characterization
Purity and apparent molecular weight of CSPB were determined
using densitometric analysis of stained SDS–PAGE gels.
For immunoblot analysis, plant- and E. coli-produced CSPB were
subjected to SDS–PAGE and transferred to a nitrocellulose mem-
brane. The blot was probed with a goat anti-CSPB speciﬁc poly-
clonal antibody raised against the E. coli-expressed CSPB protein.
Matrix-assisted laser desorption/ionization time-of-ﬂight mass
spectrometry (MALDI–TOF MS) was used to conﬁrm the identity of
CSPB by tryptic digest mapping (Aebersold, 1993; Billeci and
Stults, 1993; Hileman et al., 2006). N-terminal sequence analysis
(Hunkapiller and Hood, 1983) was performed for 15 cycles using
an Applied Biosystems 494 Procise Sequencing System. To deter-
minewhetherCSPBwasglycosylated, proteinsonaPVDFmembrane
were analyzedusing aMolecular Probes’ Pro-Q Emerald 488Glyco-
protein Blot Stain Kit (Invitrogen, Carlsbad, CA). Following glycosyl-
ation analysis, total protein on themembranewas visualizedusing a
SYPRO Ruby Protein Blot Stain kit (Invitrogen, Carlsbad, CA).
A CSPB functional activity assay was performed to analyze the
ability of CSPB to unfold an oligonucleotide-hairpin structure
(Phadtare et al., 2003, 2004). Brieﬂy, the CSPB activity was assessed
as the amount (pmol) of unfolded Dual Labeled Probe (DLP) per
microgram of CSPB. The DLP consists of a synthesized 35-base oli-
gonucleotide fragment with a ﬂuorescent label at the 50 end and a
ﬂuorescence quencher at the 30 end. The DLP was designed to form
a double stranded stem of six base pairs due to the complementary
bases located at 50 and 30 ends, while 23 nucleotides (dT) in the
middle form a loop. The ﬂuorescence was measured at an excita-
tion wavelength of 485 nm and an emission wavelength of
520 nm. The amount of opened DLP was determined using a cali-
bration curve of the ﬂuorescent tag.
2.4. Bioinformatic assessment of potential CSPB allergenicity and
toxicity
The CSPB protein sequence was translated from its correspond-
ing nucleotide sequence using standard genetic code. FASTA
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sequences in allergen (FARRP, 2014), protein (GenBank, release
199.0) and protein toxin databases. All protein sequences
(32,476,608) in GenBank Release 199 were downloaded and the
description line for each sequence was searched to see if it con-
tained the keywords ‘‘toxi’’ or ricin. Sequences (35,473) containing
the keywords were identiﬁed; each description line was reviewed
and sequences having descriptions that were consistent with pro-
tein toxicity were retained. Sequences whose descriptions did not
reﬂect toxicity, i.e. anti-toxin, non-toxin, toxin export etc. were dis-
carded. Those sequences that remained were screened to remove
duplicates resulting in 10,419 sequences that comprised the
TOX_2014 database. Each protein alignment received an E-score,
which is a composite measure of similarity between proteins that
were aligned by FASTA. When an E-score cutoff of 1 was used, no
alignments were obtained with the TOX_2014 database. By deﬁni-
tion a FASTA alignment with an E-score of 1 is what would be
observed for random sequence of the same length and amino acid
composition as CSPB. When the E-score threshold was raised to 10,
96 alignments were recovered. Among the top 5 alignments that
displayed an E-score greater than one and less than two, three clas-
ses of toxins were identiﬁed; they include RTX toxins, parasporins
and phage toxin ribonucleases. These alignments spanned no more
than 42 amino acids; they displayed no greater than 40% identity
and each of the aligning toxins from the database was greater than
598 amino acids in length. Overall, the alignments were of excep-
tionally low quality and did not indicate sufﬁcient conservation in
structure such that one would conclude that CSPB would display
the function of an RTX toxin, a parasporin or a phage toxin
ribonuclease.
An E-score of 61e5 (1  105) was set as an initial high cut-off
value for alignment signiﬁcance and represents a conservative and
inclusive measure for the identiﬁcation of proteins that are likely
to be homologous (Pearson, 2003). In addition, the allergen data-
base was screened for matches using an eight amino acid sliding
window across the CSPB sequence (Goodman et al., 2002;
Hileman et al., 2002; Silvanovich et al., 2006; Stadler and Stadler,
2003). While typically FASTA alignments with sequences from
the allergen database are examined to see if they exceeded a
threshold of 35% identity in 80 amino acids (Codex Alimentarius,
2009), this was criterion not applied due to the fact that the CSPB
protein is smaller than 80 amino acids. Instead, all FASTA align-
ments with the allergen database were inspected to conﬁrm that
no alignment displayed equal to or greater than 28 identities, the
number needed in 80 amino acids to yield 35% identity. The max-
imum number of identities observed in any alignment with the
allergen database was 17 spread over an alignment window of
50 amino acids. As with the toxin alignments, the quality of align-
ments with the allergen database was so poor that there was no
indication of conserved structure between CSPB and any allergen
sequence.
2.5. Assessment of CSPB susceptibility to pepsin and pancreatin
The susceptibility of the E. coli-produced CSPB to pepsin was
evaluated using a previously described method (Thomas et al.,
2004). Prior to treatment, the speciﬁc activity of pepsin (Sigma
Company, St. Louis, MO) was quantiﬁed. CSPB was mixed with pep-
sin solution (10 mM HCl, 2 mg/ml NaCl, pH 1.2; 10 U of pepsin
per microgram of CSPB protein) and incubated at 37 C. Samples
were removed at 0.5, 2, 5, 10, 20, 30 and 60 min and quenched with
a buffer of 0.7 M Na2CO3, pH 11. The resulting solutions were ana-
lyzed by SDS–PAGE.
Cleavage by digestive enzymes was also assessed by pepsin
treatment followed by pancreatin treatment. Pancreatin (Sigma)
was dissolved in 50 mM potassium phosphate buffer (pH 7.5) to1% (w/v) as described in The United States Pharmacopoeia
(Delaney et al., 2008b; USP, 1995). The pancreatin solution was for-
mulated so that 55.3 lg of pancreatin powder would be present
per lg of the CSPB protein in the reactions. The pepsin reaction
was halted at 2 min of incubation by adding 0.7 M sodium carbon-
ate buffer; the 2 min time point was selected to insure that the
protein fragment of interest was readily detectable on SDS–PAGE.
The quenched pepsin reaction mixture was added to a pre-heated
(37 C, 5 min) aliquot of pancreatin mixture. Samples were
removed at 0, 0.5, 2, 5, 10, 30, 60 and 120 min and quenched with
SDS–PAGE loading buffer. The resulting solutions were analyzed by
SDS–PAGE.2.6. Acute oral toxicity assessment
CD-1 mice (Charles River Laboratories, Spencerville, OH) were
acclimated for 7 days before the ﬁrst day of dosing. Prior to study
start the animals were weighed and examined in detail, and then
assigned to the study utilizing a stratiﬁed randomization technique
to obtain approximately equivalent group mean body weights for
the two treatment groups (each comprised of 10 male and 10
female CD-1 mice). The animals were approximately 8 weeks of
age at the initiation and their body weights ranged from 28.8 to
35.2 g for the males and 21.2 to 25.2 g for the females.
The CSPB dose solution was prepared by mixing E. coli-derived
CSPB in a vehicle buffer (20 mM Tris, pH 8.0) at a dose concentra-
tion of 61.7 mg/ml. A control dose solution was prepared by mixing
lyophilized BSA powder (Calbiochem, La Jolla, CA) with the vehicle
buffer to achieve a similar protein concentration to CSPB. Pre-dose,
post-dose, and homogeneity samples were collected for analysis.
After dilution, the pre- and post-dose samples were assessed for
CSPB purity and apparent molecular weight using SDS–PAGE, for
protein concentration using amino acid analysis, and functional
activity of the protein using the DLP assay described above.
The test group received the CSPB protein solution at a dose level
of 2160 mg/kg, the control group received the BSA protein solution
at a similar dose level, and the dosing solutions were administered
by oral gavage as two 17.5 ml/kg doses separated by approxi-
mately 4 h. Following dosing, all mice were subjected to detailed
clinical observations and once daily thereafter for signs of mortal-
ity or toxicity. Food consumption was measured on days 0, 7 and
14. Body weights were measured prior to dosing and on study days
0, 7 and 14. All animals were sacriﬁced on day 14 and macroscopic
exams were performed on the day of necropsy.
Data were statistically analyzed for homogeneity of variance
using Levene’s test followed by the Shapiro–Wilk test for normal-
ity. If both tests were not signiﬁcant a single-factor parametric
ANOVA followed by Dunnett’s test was used to identify statistically
signiﬁcant differences between the control group and the test arti-
cle-treated. If either test was signiﬁcant a Kruskal–Wallis non-
parametric ANOVA followed by Dunn’s test was used to identify
statistically signiﬁcant differences between the control group and
the test article-treated. The analyses were conducted with a mini-
mum signiﬁcance level of p < 0.05.3. Results
3.1. Puriﬁcation of CSPB
Initial screening demonstrated that E. coli harboring the CSPB
expression plasmid was able to produce a high level of soluble
CSPB, reaching up to 8% of the total soluble protein. Following
the optimization of puriﬁcation conditions, CSPB was puriﬁed from
5 kg of E. coli cell paste, resulting in 8 g of CSPB. A silver stained
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out any other proteins being detected (Fig. 1, lane 2).
The puriﬁcation of CSPB from the grain of DroughtGard™ was a
challenge due to the extremely low expression level of CSPB
(0.06 lg protein/g grain (USDA and Submission, 2009)). Thus,
while the methods developed for the E. coli-produced CSPB puriﬁ-
cation served as the foundation for puriﬁcation of CSPB from grain,
signiﬁcant additional process optimization was required. Grain
extracts contain lipids, starch, and ﬁbers, which complicate the
puriﬁcation process. CSPB extraction from the grain appeared to
be optimal when performed under mildly basic conditions (pH
8), low ionic strength buffers, and in the presence of a chelating
agent, but with no other additives, detergents or denaturants. Dia-
tomaceous earth also used in a ﬁltration process which not only
facilitated the ﬁltration but also assisted in the removal of lipids
and hydrophobic particles (Ward and Swiatek, 2009). The most
critical step in the isolation process was employment of immuno-
afﬁnity chromatography to capture the very limited amount of
CSPB present in the large volume of sample. To maximize yield
at this step, the CSPB-enriched sample was recirculated over the
immunoafﬁnity column multiple times to increase residence time
and maximize the capture of CSPB.
The developed method allowed 60 lg of CSPB to be obtained
from 10 kg of DroughtGard™ grain, with a purity of 97% (Fig. 1,
lane 3). Recovery of the plant-produced CSPB during the puriﬁca-
tion process is summarized in Table 1. The low abundance of the
protein in the starting material resulted in an approximately
50,000 fold puriﬁcation of CSPB relative to its concentration in
the starting extract (Table 1).
3.2. Characterization of CSPB
The identity of CSPBwas conﬁrmedusingN-terminal sequencing
(Table 2). N-terminal sequencing resulted in the expected
sequences for CSPB with the exception of the N-terminalFig. 1. SDS–PAGE of plant- and E. coli-produced CSPB. Aliquots of plant- and E. coli-
produced CSPB were separated by SDS–PAGE on a Novex 10–20% (w/v) Tricine gel
and stained with an Owl Silver Staining kit. Lane 1: molecular weight markers
(values shown at left of image indicate molecular weight/1000), lane 2: the E. coli-
produced CSPB, lane 3: the plant-produced CSPB.methionine, which was excised in the plant-produced CSPB
(Table 2). Removal of the N-terminal methionine by methionine
aminopeptidase is a common modiﬁcation that occurs co-transla-
tionally before completion of the nascent protein chain, and typi-
cally has no effect on protein structure or activity (Arﬁn and
Bradshaw, 1988; Bradshaw et al., 1998; Polevoda and Sherman,
2000).
The identity of plant- and E. coli-produced CSPB was further
conﬁrmed by tryptic peptide mass mapping using MALDI–TOF
MS analysis. The identiﬁed masses were used to assemble a cover-
age map for the entire CSPB protein. The identiﬁed peptides from
plant- and E. coli-produced CSPB resulted in 87.9% and 94% cover-
age of the entire protein sequence (Table 2, Fig. 2), respectively.
This analysis conﬁrmed the identity of both plant- and E coli-pro-
duced CSPB.
3.3. Evaluation of the equivalence between plant- and E. coli-produced
CSPB
In order to use E. coli-produced protein to assess CSPB safety, it
was important to establish the equivalence of this protein to the
CSPB protein present in DroughtGard™ maize (Gao et al., 2004;
Harrison et al., 1996; Raybould et al., 2013). Despite the very low
expression level of CSPB in the grain of DroughtGard™ maize, a
sufﬁcient amount of highly puriﬁed plant-produced CSPB was
obtained to enable this equivalence assessment. Immunoblot anal-
ysis was conducted to determine the relative immunoreactivities
of plant- and E. coli-produced CSPBs. The results demonstrated that
proteins from both sources migrated to a similar position on the
blot (Fig. 3) and showed comparable band intensities. This analysis
demonstrated that both proteins have equivalent immunoreactive
properties.
The equivalence in apparent molecular weight of plant- and E.
coli-produced CSPB was demonstrated using SDS–PAGE. The
apparent molecular weights of plant- and E. coli-produced CSPB
were 6.7 and 6.5  103 (Table 2), respectively, as assessed on sep-
arate SDS–PAGE gels. The difference in their apparent molecular
weights was 3%, which is well within typical assay variability
(Weber and Osborn, 1969). This analysis demonstrated that both
proteins have equivalent apparent molecular weights.
The speciﬁc activity to unfold RNA was determined to be
0.660 ± 0.05 pmol opened DLP/lg of the plant-produced CSPB
and 0.757 ± 0.055 pmol opened DLP/lg of the E. coli-produced
CSPB (Table 2). The difference of speciﬁc activities between CSPB
isolated from different sources was 12.8%, which was within
acceptable assay variability (15%) determined during the assay val-
idation, conﬁrming that plant- and E. coli-produced CSPB have
equivalent functional activities. This result also indicates that the
N-terminal methionine, absent in the plant-produced protein, did
not affect CSPB functional activity.
Some eukaryotic proteins are post-translationally modiﬁed by
the addition of carbohydrate moieties (Rademacher et al., 1988).
The search for glycosylation sites found two potential sites in the
CSPB protein: one O linked at T64 and one N-linked at N62 (see
Fig. 2B for amino acid positions). Because glycosylation can alter
the physiochemical properties of a protein (e.g., function, half-life),
assessing whether the plant-produced protein is glycosylated is
one component of the equivalence assessment (Raybould et al.,
2013). CSPB isolated from the grain and E. coli were each evaluated
for glycosylation, using transferrin and horseradish peroxidase
(HRP) as positive controls. The positive controls, transferrin and
HRP, were detected at the expected molecular weights of
75  103 and 50  103, respectively, in a concentration-depen-
dent manner (Fig. 4A, lanes 4–5 and 2–3). No detectable signal
was observed for the plant-produced CSPB (Fig. 4A, lanes 6 and 7)
and CSPB from E. coli (Fig. 4A, lanes 8 and 9). To conﬁrm that
Table 1
Recoveries of the plant-produced CSPB during puriﬁcation process.
Samples Total protein (g) CSPB (lg)a CSPB per total protein (lg/g) Puriﬁcation foldb
Clariﬁed extract 34.5 713 20.7 –
Diaﬁltered sample 37.5 737.1 19.7 1
Ammonium sulfate cut 19.6 725.9 37.1 1.8
Desalted sample 15.4 602 39.1 1.9
AEC pool 6.3 529.7 84.1 4.1
IAC/SEC pool N.A. 102.9 N.A. N.A.
Puriﬁed CSPB 6.1  105 59 0.97  106 46,860
Note: AEC, anion exchange chromatography; IAC, immunoafﬁnity chromatography; SEC, size exclusion chromatography; N.A., not available.
a Assayed by enzyme-linked immunosorbent assay with exception of puriﬁed CSPB sample, which was determined by densitometric scanning of an SDS–PAGE visualized
by silver staining.
b Puriﬁcation fold equals CSPB per total protein divided by the starting amount (20.7).
Table 2
Characteristics of plant- and E. coli-produced CSPB.
Characteristic Method Result
E. coli-produced Plant-produced
Purity SDS–PAGE/densitometry 100%a 97%b
Apparent molecular
weight
SDS–PAGE/densitometry 6.5  103a 6.7  103b
Activity DNA unfoldingc 0.757 ± 0.055 U 0.660 ± 0.05 U
Immunoreaction Immunoblot Immunoreactive band observed Equivalent immunoreactive band
observed
Glycosylation Molecular Probes’ Pro-Q Emerald 488 Glycoprotein Blot
Stain Kit
Not glycosylated Not glycosylated
Identity N-terminal sequence MVEGKVKWFNSEKGF VEGKVKWFNSEKGFG
MALDI–TOF MS (tryptic mass ﬁngerprint) 94.0% coverage of expected
sequence
87.9% coverage of expected sequence
a Proteins were visualized by colloidal blue staining and calculated as the average of the six loads.
b Proteins were visualized by silver staining and calculated as the average of the six loads.
c 1 U equals 1 pmol opened DLP/lg CSPB.
A
B
Fig. 2. MALDI–TOF MS coverage map of plant- and E. coli-produced CSPB. The amino acid sequence of the CSPB was deduced from the cspb gene present in DroughtGard™
maize. Boxed regions correspond to tryptic peptides that were identiﬁed from the plant- (A) and E. coli-produced CSPB (B) using MALDI–TOF MS.
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the same PVDFmembrane was incubated with SYPRO Ruby stain to
detect proteins (Fig. 4B). Both plant- and E. coli-produced CSPB
were clearly visible on the membrane (Fig. 4B, lanes 6–9). Transfer-
rin and HRP showed weak signals upon SYPRO Ruby staining, pos-
sibly due to their less sensitivity to the staining. Nonetheless, both
transferrin and HRP responded well to glycosylation staining.
N-glycosylation occurs in the secretory pathway and is well
conserved in animals, plants, fungi, and social amoebae (Bushey
et al., 2014). However, the CSPB protein is not targeted for the
secretory pathway, supporting that CSPB is not N-glycosylated. In
addition, the tryptic fragments containing potential glycosylation
sites were identiﬁed for both E. coli and plant-produced CSPB by
MALDI–TOF mass spectrometry. All identiﬁed masses matched
the expected non-modiﬁed peptide masses (Fig. 2), conﬁrming that
no glycosylation had occurred.
3.4. Bioinformatics analyses of potential CSPB allergenicity and toxicity
A key element of the safety evaluation for introduced proteins
in biotechnology-derived crops is a bioinformatic analysis to assesswhether the introduced protein shows similarity to known toxins
or allergens (Hammond et al., 2013; Kier and Petrick, 2008). Bioin-
formatics analyses were performed on the translated sequence of
the cspb coding sequence in DroughtGard™ to assess its structural
relatedness with allergens, toxins and other relevant biologically
active proteins. All alignments were thoroughly evaluated accord-
ing to criteria described in the Methods. The results of the search
comparisons showed that no relevant alignments were observed
against proteins in the allergen database (FARRP, 2014). Likewise,
no relevant alignment was observed with the translated open read-
ing frame derived from cspb as compared to proteins in the protein
toxin database. These data demonstrate the lack of sequence sim-
ilarities between the CSPB sequence and any allergenic, toxic or
biologically harmful proteins. To evaluate the similarity of CSPB
to known proteins, a FASTA search using CSPB as a query to search
GenBank release 199 was also conducted and resulted in self
identiﬁcation. Of the top 10,000 alignments, greater than 6600
were with proteins that were described as being ‘‘cold shock’’.
Among the organisms that contain an aligning cold shock protein
was Lactobacillus bulgaricus, an organism used in the production
of yogurt. The remaining alignments included patent sequences
Fig. 3. Immunoblot analysis of plant- and E. coli- produced CSPB. Aliquots of plant-
and E. coli-produced CSPB were separated by SDS–PAGE on a Novex 10–20% (w/v)
Tricine gel, and electrotransferred to a nitrocellulose membrane (pore size:
0.45 lm). The blot was probed with goat anti-CSPB speciﬁc polyclonal antibodies
and developed using an Enhanced chemiluminescence system. Lane 1: molecular
weight markers (values shown at left of image indicate molecular weight/1000),
lanes 2 and 3: the E. coli-produced CSPB, lanes 4 and 5: the plant-produced CSPB,
lanes 2 and 4: 2 ng, lanes 3 and 5: 5 ng.
Fig. 4. Glycosylation analysis of CSPB. Aliquots of plant- and E. coli-produced CSPB,
HRP (positive control) and transferrin (positive control) were separated by SDS–
PAGE on a Novex 10–20% (w/v) Tricine gel and electrotransferred to a PVDF
membrane (pore size: 0.45 lm). (A) Where present, periodate-oxidized protein-
bound carbohydrate moieties reacted with Pro-Q Emerald 488 glycoprotein stain
and emitted a ﬂuorescent signal at 488 nm (lanes 2–5 and 10). (B) The same blot
was stained with SYPRO Ruby to demonstrate the protein loading. The signal was
captured using a Bio-Rad Molecular Imager FX. Lane 1: molecular weight markers
(values shown at left of image indicate molecular weight/1000); lanes 2 and 3: HRP;
lanes 4 and 5: transferrin; lanes 6 and 7: the plant-produced CSPB; lanes 8 and 9:
the E. coli-produced CSPB; lane 10: CandyCane glycosylated protein markers; lanes
2, 4, 6 and 8: 25 ng; lanes 3, 5, 7 and 9: 50 ng.
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sequencing projects.
3.5. Assessment of CSPB susceptibility to digestive enzymes
An assessment of CSPB susceptibility to pepsin was conducted
using a standardized assay (Thomas et al., 2004). Cleavage of the
CSPB protein by pepsin was evaluated by visual analysis of stained
polyacrylamide gel (Fig. 5A). The limit of detection (LOD) of the CSPB
protein by Colloidal Brilliant Blue G staining was observed at
approximately 0.005 lg or approximately 0.6% of the total CSPB
protein loaded (Supplemental Fig. 1).Western blot analysis was also
conducted (Supplemental Fig. 2); the LOD of the CSPB protein by
western blotting was observed at approximately 0.1 ng or approxi-
mately 1% of the total CSPB protein loaded (Supplemental Fig. 3).
Visual examination of a stained gel (Fig. 5A) showed that the full-
length CSPB protein was degraded below LOD within 0.5 min of
exposure to pepsin (Fig. 5A, lane 5). Therefore, based on the LOD,
at least 99% of the CSPB protein was degraded by pepsin within
0.5 min. A transiently-stable protein fragment with an apparent
molecular weight of 2.5 103 was observed between the 0.5
and 30 min time points. The relative abundance of the transient
fragment to the CSPB protein initially loaded was estimated by den-
sitometry. At the 10 and 30 min time points, the transient fragment
band had an intensity of 11.8% and 2.6% of the intact CSPB protein
found at the 0 min time point, respectively. This fragment was
derived from the N-terminus of the CSPB protein (data not shown).
No CSPB fragmentswere visible at the 60 min time point (Fig. 5, lane
11) indicating complete degradation of the protein by pepsin.
To better understand the degradation fate of the transiently sta-
ble CSPB fragment, an assessment of the susceptibility of this frag-
ment to pancreatin and neutral pH was conducted (Fig. 5B). After
CSPB treatment with pepsin for 2 min, the reaction was quenched
and the transiently stable 2.5  103 CSPB protein fragment was
exposed to pancreatin. The cleavage of the CSPB-derived fragment
by pancreatin was evaluated by SDS–PAGE (Fig. 5B). Visual exam-
ination of the stained gel demonstrated that this fragment wasdegraded by pancreatin within 0.5 min, the ﬁrst time point
assessed (Fig. 5B, lane 7).
3.6. Assessment of potential oral toxicity of CSPB
In addition to the above data, demonstrating that CSPB is not a
hazard, further conﬁrmation of safety was demonstrated with an
acute toxicity test for the CSPB protein. The test group mice were
dosed at 2160 mg CSPB/kg body weight. A dose level of BSA com-
parable to the CSPB dose levels served as the control formulation.
The dose formulation was analyzed for CSPB concentration, homo-
geneity, stability and activity and met all of the acceptability crite-
ria for those parameters (data not shown). The animals were dosed
on Day 0 and observed for 14 additional days. All animals were
healthy, and no mortality or CSPB-related clinical signs were
observed. CSPB did not affect body weight (Table 3), or food con-
sumption (Table 4), and no abnormal gross necropsy ﬁndings were
present at study completion. For the purposes of assessing dietary
exposure, the no observable adverse effect levels (NOAEL) for CSPB
was considered to be 2160 mg/kg for the study.
3.7. Assessment of dietary exposure to CSPB
To estimate dietary exposure to CSPB, the expression level of
the protein in DroughtGard™ grain and the consumption of maize
Fig. 5. Colloidal Brilliant Blue G stained SDS-gels of CSPB protein digestion. Panel A
corresponds to CSPB protein digestion by pepsin. Based on pre-digestion protein
concentrations, 0.8 lg CSPB protein was loaded in lanes containing CSPB protein.
The incubation times are indicated. Lanes 1 and 14: molecular weight markers
(values shown at left of image indicate molecular weight/1000), lanes 2 and 13:
pepsin only, lanes 3 and 12: CSPB only, lanes 4–11: a time course of pepsin
digestion. Panel B: After digestion of the CSPB protein by pepsin for 2 min, the
reaction was quenched and the transiently stable CSPB protein fragment was
exposed to further digestion by pancreatin. Based on protein concentrations before
digestion by pepsin, 0.8 lg of total protein was loaded per lane containing CSPB
protein. Lanes 1: molecular weight markers (values shown at left of image indicate
molecular weight/1000), lane 2: pepsin reaction mixture, lane 3: 2 min after
digestion of CSPB by pepsin, lanes 4 and 15: pancreatin mixture only, lanes 5 and
14: no pancreatin added to reaction, lanes 6–13: a time course of pancreatin
digestion. 2 h, 2 hours.
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expression level in DroughtGard™ grain grown in the U.S. during
2006 was 0.063 lg/g fresh weight (USDA and Submission, 2009).Table 3
Summary of body weight data observed in the acute oral toxicity study in mice.
Group Timea
Day 0 Day 7 Change (d
Male Female Male Female Male
CSPB 31.2 (1.75) 23.4 (1.03) 34.1 (2.73) 25.6 (1.21) 2.9 (1.55)
BSA 31.4 (1.42) 23.5 (1.15) 34.0 (1.45) 25.1 (1.63) 2.6 (1.07)
a Values correspond to the mean body weight (and standard deviation) of 10 animals
Table 4
Summary of food consumption data observed in the acute oral toxicity study in mice.
Group Timea
Change (day 0 to day 7) g animal1 day1
Male Female
CSPB 7.0 (1.60) 6.1 (0.75)
BSA 7.3 (1.78) 5.9 (0.41)
a Values correspond to the mean (and standard deviation) of 10 animals per group.This protein expression estimate is a conservative estimate of CSPB
concentration in food derived from DroughtGard™ maize because
it assumes no loss of the CSPB protein during storage, processing
and/or cooking of the grain or food. The highest 97.5th percentile
consumption estimates for acute (single-day ‘‘eaters only’’) con-
sumption of maize and maize-derived products were according
to the GEMS/Food database (WHO, 2011). These values were
selected because they are the highest reported values world-wide
and represent a reasonable estimate of the maximum amount of
maize that might be consumed in a single day. The acute consump-
tion of maize ﬂour in the general population and children aged six
years and younger was derived from food consumption surveys in
France and Australia, respectively. The consumption values in the
general population and children aged six for sweet corn and pop-
corn were derived from food consumption surveys in Thailand
and Japan, respectively. Additionally, most maize products, with
the exception of maize on the cob, are blended commodities. This
makes it very difﬁcult to estimate the percentage of consumed
maize products that will be derived from DroughtGard™. As a
result, the conservative assumption was made that 100% of all
maize products consumed would be derived from DroughtGard™.
As one of many commercial maize varieties currently grown,
DroughtGard™ would represent only a small fraction of the maize
used to prepare maize food products. Based on these high-level
consumption values and the level of expression of CSPB in
DroughtGard™ maize grain, the dietary intakes of CSPB from these
maize and maize-derived products were calculated and are shown
in Table 5. These CSPB intake values were then used to calculate
the margin of exposure (MOE) for acute dietary intake of CSPB from
maize and maize products containing DroughtGard™ compared to
acute toxicity study NOAEL of 2160 mg/kg (Table 5), which was the
highest dose tested. The results indicate very large MOEs that
areP 3.0  106 even when human exposure to CSPB is generously
estimated due to the conservative assumptions made in the expo-
sure assessment.
4. Discussion
An essential component of the safety assessment of biotechnol-
ogy-derived crops is evaluation of the safety of newly expressed
proteins (Delaney et al., 2008a; Hammond et al., 2013; Herouet
et al., 2005; Kier and Petrick, 2008). This comprehensive safety
assessment includes: (1) the evaluation of the history of safe use
of the donor organism and the protein itself, (2) examination of
the mechanism of action of the introduced protein, (3) examinationay 0 to day 7) Day 14 Change (day 0 to day 14)
Female Male Female Male Female
2.2 (1.07) 35.6 (3.35) 26.9 (1.29) 4.4 (2.13) 3.5 (0.99)
1.6 (1.33) 36.4 (1.60) 27.4 (1.60) 5.1 (1.68) 3.9 (0.88)
in units of grams.
Change (day 7 to day 14) g animal1 day1
Male Female
7.2 (1.57) 6.3 (0.66)
7.0 (0.46) 6.3 (1.00)
Table 5
Risk assessment/margin of exposure.
Population Consumption of food itema (g/kg/day) CSPB intakeb (lg/kg/day) Margin of exposurec
Maize ﬂour
General population (97.5th percentile ‘‘eater-only’’, acute value) 2.04 0.129 1.7  107
Children 6 6 years (97.5th percentile ‘‘eater-only’’, acute value) 3.16 0.199 1.1  107
Popcorn
General population (97.5th percentile ‘‘eater-only’’, acute value) 3.33 0.210 1.0  107
Children 6 6 years (97.5th percentile ‘‘eater-only’’, acute value) 3.33 0.210 1.0  107
Sweet corn
General population (97.5th percentile ‘‘eater-only’’, acute value) 7.16 0.451 4.8  106
Children 6 6 years (97.5th percentile ‘‘eater-only’’, acute value) 11.52 0.726 3.0  106
a Estimates of acute consumption were obtained from the WHO Global Environmental Monitoring System (WHO, 2011).
b Assumes 100% of maize-derived food was derived from DroughtGard™ maize and contains 0.063 lg/g (ppm) CSPB (USDA and Submission, 2009).
c Calculated by dividing NOAEL from acute mouse gavage study (2160 mg/kg/day) by CSPB intake. MOEs rounded to two signiﬁcant digits.
C. Wang et al. / Regulatory Toxicology and Pharmacology 71 (2015) 164–173 171of the similarity of the protein to known allergens and toxins, (4)
characterization of the physicochemical and functional properties
of the protein, (5) evaluation of the digestibility of the protein by
pepsin, (6) a toxicity assessment, and (7) an intake assessment.
CSPB is derived from B. subtilis, a microorganism with a history
of safe use in fermented foods and probiotics (De Boer and
Diderichsen, 1991; Hosoi et al., 2003; Sanders et al., 2003). B. sub-
tilis has been used in production of food for hundreds of years
(Ashikaga et al., 2000; FDA, 1999; Inatsu et al., 2006; OECD,
2001). In addition, B. subtilis was tested for cytotoxicity in Chinese
hamster ovary K1 (CHO-K1) cells, for production of hemolytic and
nonhemolytic enterotoxins (Pedersen et al., 2002), acute toxicity in
BALB/c mice, and chronic toxicity in mice, rabbits, and pigs
(Sorokulova et al., 2008). No toxic effects were attributed to B. sub-
tilis in these studies and no similarities to pathogenic bacteria were
found, which led to the conclusion that B. subtilis, the donor organ-
ism for CSPB, is safe for human consumption (Pedersen et al., 2002;
Sorokulova et al., 2008).
CSPB is similar to other CSPs and related proteins found in many
bacteria and plants, including those used for food (Graumann and
Marahiel, 1999; Karlson and Imai, 2003; Nakaminami et al., 2006).
This family includes bacterial and plant proteins possessing a CSD
that has high amino acid sequence similarity to the sequence of the
CSPB protein (Graumann et al., 1997; Karlson and Imai, 2003;
Nakaminami et al., 2006). CSPB from B. subtilis is homologous to
the CSP proteins found in Lactobacillus, Lactococcous, and Biﬁdobac-
terium species, the most common types of bacteria used in the
dairy industry to prepare cheese, sour cream, buttermilk, yogurt
and probiotic products containing live bacterial cultures (Morea
et al., 2001; Ogier et al., 2002). Plant proteins with CSDs that have
high similarity to the CSPB protein are present in many crops. Thus,
the CSPB protein expressed in DroughtGard™ maize is similar to
several bacterial CSPs and CSD-containing proteins present in the
human diet and directly consumed in common foods, establishing
a history of safe exposure for this protein.
Plant CSD proteins, like bacterial CSPs, accumulate in response
to cold (Fusaro et al., 2007; Nakaminami et al., 2006, 2005), and
exhibit in vitro nucleic acid binding activity with a low sequence
speciﬁcity. The CSD-proteins have been shown to bind and desta-
bilize RNA secondary structures (Sasaki et al., 2007), suggesting
that CSD proteins regulate stress responses in plants through
mechanisms similar to those described for CSP proteins in bacteria.
A plant CSD protein has been shown to rescue a cold-sensitive E.
coli CSP knockout mutant (Nakaminami et al., 2006), indicating
conserved functions between bacterial CSP and plant CSD-contain-
ing proteins. The transgenic maize plants expressing the CSPB pro-
tein demonstrated yield improvement under water-limited
conditions (Castiglioni et al., 2008). However, disruption of the
nucleic acid binding activity of CSPB by single amino acid mutation
abolished the ability of the CSPB protein to confer maize yieldbeneﬁts under water stress (Castiglioni et al., 2008). The loss of
drought tolerance phenotype by expression of the CSPB functional
mutant indicated that CSPB likely moderates drought responses in
DroughtGard™ maize through a similar mechanism to CSD-con-
taining proteins in plants, possibly through destabilization of
RNA secondary structures. This conserved function between CSPB
in DroughtGard™ maize and CSD-containing proteins in plant sup-
ports a lack of a safety concern with respect to CSPB’s mechanism
of action.
Bioinformatic analysis of amino acid sequences addresses a fun-
damental safety question: does the introduced protein share any
sequence or structural similarity with proteins known to pose pos-
sible hazards? Because high sequence and structural similarity
often correlates with a conserved biological role, bioinformatic
analysis provides an important assessment of the potential for pro-
tein toxicity or allergenicity (Hammond et al., 2013). The analyses
demonstrated that no structurally relevant similarity exists
between CSPB and known toxic, allergenic, or other biologically
active proteins that would be harmful to human or animal health.
An absence of homology between CSPB and known allergens and
protein toxins supports the conclusion that CSPB is not a hazard.
While both the history of safe use and bioinformatics analyses
indicate that the consumption of the CSPB protein is safe, addi-
tional safety studies were conducted because it is the ﬁrst known
RNA-unfolding protein used in the context of agricultural biotech-
nology. A challenge for the safety assessment of proteins expressed
in crops is producing enough high quality protein to perform safety
assessments. Because the expression of CSPB in grain of Drought-
Gard™ is very low, it is not technically feasible to obtain sufﬁcient
quantities of CSPB for safety assessment from grain. In such cir-
cumstances, it is acceptable for the needed quantity of the protein
to be produced from an alternative source, such as E. coli (Gao et al.,
2004; Harrison et al., 1996; Herouet et al., 2005). However, a small
amount of protein must still be puriﬁed from the plant to assess its
equivalence to the E. coli-produced protein. In this study, both
plant- and E. coli-produced CSPB were physicochemically and func-
tionally characterized, and the equivalence between them was
demonstrated according to Codex and other published guidelines
(Codex Alimentarius, 2009; Gao et al., 2004; Harrison et al.,
1996; Herouet et al., 2005; Raybould et al., 2013). Accordingly,
the E. coli-produced CSPB protein is considered suitable for con-
ducting safety assessments of the CSPB protein present in
DroughtGard™.
Although the correlation between allergenicity and pepsin
resistance is imperfect (Herman et al., 2006), some proteins that
are food allergens are relatively resistant to pepsin digestion
(Asero et al., 2000; Astwood et al., 1996; Yagami et al., 2000). As
a result, evaluation of the susceptibility of the protein of interest
to digestion by the gastric enzyme pepsin is an important element
of the safety assessment for introduced proteins (Codex
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vides evidence that exposure to the introduced protein will be
minimized following consumption (Hammond et al., 2013; Kier
and Petrick, 2008). The full length CSPB was rapidly degraded by
pepsin (none detectable after 0.5 min incubation), and a small
(2.5  103) transiently stable fragment was completely degraded
after 60 min by pepsin. During human gastrointestinal digestion,
protein or protein fragment(s) must ﬁrst pass through the stomach
where they are exposed to pepsin and then the duodenum where
they are exposed to pancreatin. The pepsin-released CSPB fragment
is less than 3  103 and is only transiently present during pepsin
digestion. Therefore, it is unlikely that such fragment will pose a
potential allergenic risk (Ofori-Anti et al., 2008). However, in
instances where transient stability of a protein or protein fragment
is observed in pepsin cleavage, sequential degradation of the frag-
ment by pepsin followed by pancreatin has been recommended
(Bushey et al., 2014; Delaney et al., 2008a). For that reason, an
assessment of the susceptibility of this CSPB fragment to pancrea-
tin was conducted. It was observed that this fragment is rapidly
degraded by pancreatin within 0.5 min. Thus, CSPB is highly sus-
ceptible to mammalian digestive enzymes, a result consistent with
the conclusion that CSPB is safe for consumption.
As discussed above, CSPB protein (1) has a history of safe use;
(2) is not structurally or functionally related to known toxins or
allergens; (3) has a nucleic acid binding activity conserved in the
CSD family of proteins; (4) is readily cleaved by mammalian diges-
tive enzymes; and (5) has a very low expression level in Drought-
Gard™. Thus, the weight of evidence supports that CSPB is not a
hazard to people (Hammond et al., 2013). However, experimental
evaluation of potential toxicity of CSPB was still conducted to fur-
ther assess the safety of CSPB. An acute toxicity study is the appro-
priate test to examine that CSPB is not toxic (Pariza and Johnson,
2001), because most known protein toxins exert toxicity through
acute mechanisms (Pariza and Johnson, 2001; Sjoblad et al., 1992).
The NOAEL is the dose that causes no adverse effects in test ani-
mals, and is used to establish a safe level of exposure for humans. A
protein toxicity test, with a dose of 2160 mg CSPB/kg body weight,
resulted in no adverse impacts on the treatment animals and
established 2160 mg CSPB/kg as the NOAEL. This NOAEL and esti-
mates of dietary intake of CSPB were used to calculate MOEs for
CSPB in maize and maize products that could be derived from
DroughtGard™ (i.e., 100% of maize consumed is DroughtGardTM
and no CSPB is lost due to storage, processing, or cooking). All
MOEs wereP 3  106, or more than six orders of magnitude
higher than generous estimates for human exposure to CSPB from
consumption of DroughtGard™ maize. Moreover, given the low
expression of CSPB in DroughtGard™ maize (average 0.063 lg pro-
tein/g) a 60 kg human would have to eat approximately
2.1  106 kg of DroughtGard™ maize in a single day to achieve
an intake level similar to the NOAEL of the acute toxicity study
(2160 mg/kg). These results indicate that there are no meaningful
risks to human health from dietary exposure to the CSPB protein
derived from DroughtGard™.
Acute toxicity studies of introduced proteins may be conducted
in mice at a high dose of 2000 mg/kg via oral gavage, the dose of
which is designed for testing of chemicals (OECD, 2001). However,
the CSPB dose level tested in this case becomes irrelevant to a real-
istic dietary exposure as the MOE wasP 3  106.
5. Conclusions
As part of the safety assessment of GM crops, the introduced
protein was characterized and assessed in a battery of tests. These
analyses included an evaluation of the history of safe use of the
CSPB protein, bioinformatics analyses of the similarity of CSPB to
known allergens, toxins, and anti-nutritional proteins, anassessment of cleavage by mammalian digestive enzymes, acute
toxicity testing of the CSPB protein and an assessment of consump-
tion of CSPB from DroughtGard™ maize. The outcome of these
analyses support the conclusion that the CSPB expressed in
DroughtGard™ is safe for consumption in food and feed.
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